NPI: 1992041149 · GLENDALE, CA 91205 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/17/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 12/17/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,359 | $2.66M |
| 2019 | 8,616 | $854K |
| 2020 | 12,475 | $772K |
| 2021 | 15,319 | $896K |
| 2022 | 11,371 | $896K |
| 2023 | 13,104 | $1.53M |
| 2024 | 12,162 | $1.46M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 47,794 | 4,793 | $7.38M |
| 0821 | 692 | 330 | $1.22M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,286 | 1,886 | $189K |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,857 | 1,099 | $168K |
| J1756 | Injection, iron sucrose, 1 mg | 5,417 | 1,903 | $41K |
| A4657 | Syringe, with or without needle, each | 3,247 | 1,858 | $20K |
| 83970 | 1,437 | 1,407 | $11K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 667 | 406 | $6K |
| 85048 | 1,350 | 1,297 | $5K | |
| 85041 | 1,319 | 1,267 | $5K | |
| 82728 | 944 | 927 | $4K | |
| 83550 | 963 | 937 | $4K | |
| 83540 | 976 | 949 | $4K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 176 | 105 | $2K |
| 90674 | 108 | 108 | $1K | |
| 90662 | 129 | 126 | $1K | |
| G0009 | Administration of pneumococcal vaccine | 28 | 28 | $760.17 |
| 90670 | 36 | 36 | $361.19 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 37 | 31 | $328.37 |
| 0250 | 1,627 | 90 | $314.64 | |
| 90661 | 14 | 14 | $144.36 | |
| G0008 | Administration of influenza virus vaccine | 110 | 107 | $135.51 |
| 0302 | 158 | 128 | $11.66 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 34 | 34 | $4.61 |